CPC Biocast
CPC Biocast
Podcast Description
CPC Biocast is a podcast focused on bioprocessing in the biopharma and cell & gene therapy industries designed to educate, discuss relevant topics with industry experts and to provide best practices.
Podcast Insights
Content Themes
The podcast centers on key themes such as bioprocessing innovations, modularity in manufacturing, and best practices in biopharma and cell & gene therapy. For instance, the pilot episode explores modularity, focusing on topics like the revolution of the single-use industry, the distinctions between 'Big-S' and 'Little-S' in standardization, and the implications of supply chain challenges for modular adoption.
CPC Biocast is a podcast focused on bioprocessing in the biopharma and cell & gene therapy industries designed to educate, discuss relevant topics with industry experts and to provide best practices.
How MicroCNX® Connectors Enable Scalable Cell and Gene Therapy Manufacturing
Originally aired on Cell Culture Dish
In this podcast, we spoke with Troy Ostreng, Senior Product Manager and David Burdge, Director of Cell and Gene Therapy at CPC about the development of the MicroCNX® aseptic micro-connectors and how they’re helping biopharma teams streamline closed-system operations for cell and gene therapies. What unfolded was a detailed and forward-looking conversation that touched on CPC’s 47-year legacy, the technical demands of advanced therapies, and the company’s plans to drive the future of automation and sterility in manufacturing.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.